162 related articles for article (PubMed ID: 33936480)
1. Inferring ADR causality by predicting the Naranjo Score from Clinical Notes.
Rawat BPS; Jagannatha A; Liu F; Yu H
AMIA Annu Symp Proc; 2020; 2020():1041-1049. PubMed ID: 33936480
[TBL] [Abstract][Full Text] [Related]
2. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different methods for causality assessment of adverse drug reactions.
Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
[TBL] [Abstract][Full Text] [Related]
5. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
More SA; Atal S; Mishra PS
J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.
Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM
Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659
[TBL] [Abstract][Full Text] [Related]
7. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
Comfort S; Dorrell D; Meireis S; Fine J
Drug Saf; 2018 Nov; 41(11):1073-1085. PubMed ID: 29876835
[TBL] [Abstract][Full Text] [Related]
8. Naranjo Question Answering using End-to-End Multi-task Learning Model.
Rawat BPS; Li F; Yu H
KDD; 2019 Aug; 2019():2547-2555. PubMed ID: 31799022
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study.
Um SH; Abuzgaia A; Rieder M
Br J Clin Pharmacol; 2023 Aug; 89(8):2407-2412. PubMed ID: 36849649
[TBL] [Abstract][Full Text] [Related]
10. Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool.
Leopoldino RWD; de Oliveira LVS; Fernandes FEM; de Lima Costa HTM; Vale LMP; Oliveira AG; Martins RR
Int J Clin Pharm; 2023 Aug; 45(4):1007-1013. PubMed ID: 37212967
[TBL] [Abstract][Full Text] [Related]
11. Algorithmic Identification of Treatment-Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease.
Silverman AL; Sushil M; Bhasuran B; Ludwig D; Buchanan J; Racz R; Parakala M; El-Kamary S; Ahima O; Belov A; Choi L; Billings M; Li Y; Habal N; Liu Q; Tiwari J; Butte AJ; Rudrapatna VA
Clin Pharmacol Ther; 2024 Jun; 115(6):1391-1399. PubMed ID: 38459719
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
13. Toward Kidney-Specific Causality Assessment Tool.
Kaya M; Duru M; Gulmez SE
Clin Ther; 2022 Jul; 44(7):e59-e75. PubMed ID: 35725506
[TBL] [Abstract][Full Text] [Related]
14. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
Pandit S; Soni D; Krishnamurthy B; Belhekar MN
J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
[TBL] [Abstract][Full Text] [Related]
15. Confidence and accuracy in identification of adverse drug reactions reported by outpatients.
Kampichit S; Pratipanawatr T; Jarernsiripornkul N
Int J Clin Pharm; 2018 Dec; 40(6):1559-1567. PubMed ID: 30367372
[TBL] [Abstract][Full Text] [Related]
16. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.
Tillman EM; Suppes SL; Feldman K; Goldman JL
J Clin Pharmacol; 2021 Feb; 61(2):181-186. PubMed ID: 32776356
[TBL] [Abstract][Full Text] [Related]
19. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
Belhekar MN; Taur SR; Munshi RP
Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
[TBL] [Abstract][Full Text] [Related]
20. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
